Literature DB >> 16314474

Muscle wasting induced by HTLV-1 tax-1 protein: an in vitro and in vivo study.

Simona Ozden1, Vincent Mouly, Marie-Christine Prevost, Antoine Gessain, Gillian Butler-Browne, Pierre-Emmanuel Ceccaldi.   

Abstract

Besides tropical spastic paraparesis/human T-cell leukemia virus type-1 (HTLV-1)-associated myelopathy, the human retrovirus HTLV-1 causes inflammatory disorders such as myositis. Although the pathogenesis of HTLV-1-associated myositis is primarily unknown, a direct effect of cytokines or viral proteins in myocytotoxicity is suspected. We have developed an in vitro cell culture model to study the interactions between primary human muscle cells and HTLV-1 chronically infected cells. When HTLV-1-infected cell lines were added to differentiated muscle cultures, cytopathic changes such as fiber shrinking were observed as early as 1 day after contact. This was accompanied by alterations in desmin and vimentin organization, occurring in the absence of muscle cell infection but with Tax-1 present in myotubes. Cytopathic changes were also observed when infected culture supernatants were added to the muscle cells. Fiber atrophy and cytoskeletal disorganization were confirmed in muscle biopsies from two HTLV-1-infected patients with myositis. Transduction of cultured muscle cells with a lentiviral vector containing the HTLV-1 Tax gene reproduced such effects in vitro. The present data indicate that the myocytotoxicity that is observed in HTLV-1-associated myopathies can be due to a direct effect of the Tax-1 protein expressed in infected inflammatory cells, in the absence of muscle cell infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314474      PMCID: PMC1613204          DOI: 10.1016/S0002-9440(10)61245-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

1.  Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy.

Authors:  S Ozden; A Gessain; O Gout; J Mikol
Journal:  Clin Infect Dis       Date:  2001-01-24       Impact factor: 9.079

Review 2.  Desmin-related myopathies in mice and man.

Authors:  L Carlsson; L E Thornell
Journal:  Acta Physiol Scand       Date:  2001-03

3.  Inflammatory myopathy on HTLV-I infection: case report.

Authors:  R H Scola; L C Werneck; M E Heinig; J B Milano; S M Almeida; W O Arruda
Journal:  Arq Neuropsiquiatr       Date:  2001-03       Impact factor: 1.420

4.  HTLV-1 associated polymyositis in Jamaica.

Authors:  D T Gilbert; O Morgan; M F Smikle; D Simeon; E N Barton
Journal:  Acta Neurol Scand       Date:  2001-08       Impact factor: 3.209

Review 5.  Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.

Authors:  Frank L Mastaglia; Michael J Garlepp; Beverley A Phillips; Paul J Zilko
Journal:  Muscle Nerve       Date:  2003-04       Impact factor: 3.217

6.  Specific interaction of HTLV tax protein and a human type IV neuronal intermediate filament protein.

Authors:  T R Reddy; X Li; Y Jones; M H Ellisman; G Y Ching; R K Liem; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

7.  Human T cell leukemia virus type I Tax enhances IL-4 gene expression in T cells.

Authors:  M Li-Weber; M Giaisi; K Chlichlia; K Khazaie; P H Krammer
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

8.  [Polymyositis and HTLV-I infection: case report].

Authors:  H A Oliveira; J C Macieira; R Fakhouri
Journal:  Arq Neuropsiquiatr       Date:  2000-09       Impact factor: 1.420

Review 9.  Mechanisms of caspase activation and inhibition during apoptosis.

Authors:  Yigong Shi
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

10.  Efficient transfer of HTLV-1 tax gene in various primary and immortalized cells using a flap lentiviral vector.

Authors:  Christelle Royer-Leveau; Elodie Mordelet; Frédéric Delebecque; Antoine Gessain; Pierre Charneau; Simona Ozden
Journal:  J Virol Methods       Date:  2002-08       Impact factor: 2.014

View more
  4 in total

1.  New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa.

Authors:  Sonia Lekana-Douki Etenna; Mélanie Caron; Guillaume Besson; Maria Makuwa; Antoine Gessain; Antoine Mahé; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

2.  Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells.

Authors:  Razie Amraei; Chaoshuang Xia; Judith Olejnik; Mitchell R White; Marc A Napoleon; Saran Lotfollahzadeh; Blake M Hauser; Aaron G Schmidt; Vipul Chitalia; Elke Mühlberger; Catherine E Costello; Nader Rahimi
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-08       Impact factor: 11.205

3.  Human muscle satellite cells as targets of Chikungunya virus infection.

Authors:  Simona Ozden; Michel Huerre; Jean-Pierre Riviere; Lark L Coffey; Philippe V Afonso; Vincent Mouly; Jean de Monredon; Jean-Christophe Roger; Mohamed El Amrani; Jean-Luc Yvin; Marie-Christine Jaffar; Marie-Pascale Frenkiel; Marion Sourisseau; Olivier Schwartz; Gillian Butler-Browne; Philippe Desprès; Antoine Gessain; Pierre-Emmanuel Ceccaldi
Journal:  PLoS One       Date:  2007-06-13       Impact factor: 3.240

4.  Vimentin as a target for the treatment of COVID-19.

Authors:  Zhenlin Li; Denise Paulin; Patrick Lacolley; Dario Coletti; Onnik Agbulut
Journal:  BMJ Open Respir Res       Date:  2020-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.